Veranova

Last updated
Veranova
FormerlyJ.F. Macfarlan Ltd (1780–1829)
J.F. Macfarlan and Co Ltd. (1830–1961)
Edinburgh Pharmaceutical Industries (1962)
Macfarlan Smith Ltd (1963–1989)
Meconic (1990–2000)
Johnson Matthey Health (2001–2022)
Company type Limited Partnership
Industry Contract development and manufacturing organization (CDMO)
Headquarters435 Devon Park Drive, Suite 400, Wayne, PA. 19807
Area served
Worldwide
Key people
Mike Riley (CEO)
Website https://veranova.com/

Veranova, L.P. (formally Johnson Matthey Health) is an American multinational contract development and manufacturing organization (CDMO) based in Wayne, PA, with operations in North America and Europe. [1]

Contents

The company focuses on the process, development, and manufacturing of active pharmaceutical ingredients (APIs), particularly specialty and highly regulated, complex chemistries. [2] It has two divisions, Generics and Originators. Its specialized drug development and manufacturing technologies and expertise in the pharmaceutical and biotechnology industries span the drug development lifecycle. [1] [3]

Johnson Matthey Health was purchased in 2022 by Altaris Capital Partners for £325 million (JM retaining 30% equity) and rebranded to become Veranova; the name originates from the combined Latin words ‘vērus’, meaning ‘true’, and ‘nŏvus’, meaning ‘new’. [3] [4]

History

19th Century

J.F. Macfarlan, Duncan Flockhart, and T&S Smith

Through its original founding companies, the history of Veranova can be dated back to 1780, when the Edinburgh apothecary supplier, J.F. Macfarlan, was founded. [5] In 1815, John Fletcher Macfarlan, a licentiate of the Membership of the Royal Colleges of Surgeons, became the owner of the family business and acquired the apothecary shop on Edinburgh’s High Street where he began manufacturing the opium derivative laudanum. [5] [6] In 1830, a partnership was established with Macfarlan’s former apprentice, David Rennie Brown, and the business became J. F. Macfarlan and Co. [6] By 1832, J.F. Macfarlan and Co. was manufacturing morphine acetate (medicinal heroin) and hydrochloride, resulting in the development and production of anesthetics including synthetic chloroform and diethyl ether. [6] J.F. Macfarlan collaborated with Joseph Lister, known as the father of modern surgery, to start production of the first sterile dressings in 1870. [7]

In 1827, Thomas and Henry Smith established T&S Smith. Initially producing photographic paper and chemicals, it went on to be the first business to develop apomorphine in large amounts for commercial use. [5] Not long after T&S Smith was established, William Flockhart, an Edinburgh-based pharmacy, started manufacturing chloroform and laudanum. [5]

In 1817, Percival Norton Johnson set up a gold assaying business in London, and in 1851, George Matthey joined, forming Johnson Matthey (JM). [6]

20th Century

Macfarlan Smith, Meconic

During World War I, T&H Smith and Duncan Folkhart produced morphine and chloroform for medicinal purposes. Throughout the war, J.F. Macfarlan produced approximately 200 tonnes of medicated lint, 7.5 million bandages, and 1477 kilometers of gauze. [5] In 1952, T&H Smith bought Duncan Flockhart and rebranded it as Smith Duncan Flockhart. [8] It went on to produce Bitrex (denatonium benzoate), the world's most bitter substance in 1958. [7]

In 1962, Smith Duncan Flockhart merged with J.F. Macfarlan to form Edinburgh Pharmaceuticals, which in 1965 was bought by Glaxo Group and rebranded as Macfarlan Smith Ltd. [5]

In the 1980s, JM was commercializing platinum-based anti-cancer drugs cisplatin, discovered by JM and Michigan State University in 1970 and expanding into controlled substances. [7] In 1983, JM augmented its API capabilities by opening a manufacturing plant in West Deptford, NJ. [7]

The largest management buy-out in Scotland saw Macfarlan Smith become part of Meconic plc, which was floated on the London Stock Exchange in 1993. [5]

21st Century

Sale of JM Health and rebranding to Veranova

JM acquired Meconic in 2001, becoming Johnson Matthey Health (JM Health), and in 2002 bought Pharm-Eco Labs to strengthen JM Health’s API offerings. [5] In 2010, JM Health developed its biocatalysis division by purchasing X-Zyme and expanded into China with facilities in Yantai and Shanghai. [7]

2014 saw JM Health purchase Glaxo-Smith-Klein's (GSK) former manufacturing site in Annan, Scotland. [7] Investment into this site led to successful Medicines and Healthcare Products Regulatory Agency (MHRA) Good Manufacturing Practice certification in 2016. [7] In 2015, JM Health bought Pharmorphix® from Sigma-Aldrich, constituting an expansion of the company’s solid-state capabilities. Today, Pharmorphix® is the solid form and particle engineering division of Veranova. [7]

In 2021, JM sold its Health division to the US-based healthcare investment firm Altaris Capital Partners LLC (Altaris). [9] JM Health was sold for £325 million enterprise value, with JM retaining 30% equity. [10]

At the time of sale, JM Health had over 900 employees and had taken an underlying operating profit of £31 million in the previous tax year. Altaris moved JM Health HQ to Wayne, Pennsylvania while also keeping its existing facilities in the UK. [11]

Altaris rebranded JM Health as Veranova in 2022. [3] Veranova became an independent company in June 2022 with Niek Stapel as its chief executive officer (CEO). [12] In 2023, Mike Riley took over the role of CEO. Riley appointed Veranova’s Advisory Board, John Nason, Carlo de Notaristefani, Edward Robinson, and Nobel Prize winner Dr Carolyn Bertozzi, to help guide the company scientifically and strategically. [13]

In 2023, Veranova completed a $17 million expansion of its active ingredient (API) manufacturing capabilities in Edinburgh, Scotland. [14]

Operations

Veranova operates within two divisions, Generics and Originators. As a CDMO, Veranova has a range of different offerings within the drug development lifecycle, lying within their Custom Pharma Solutions and Solid Form and Particle Engineering offerings.

Sites

Veranova has its HQ in Wayne, PA with additional sites across the US in Devens and North Andover, MA, and West Deptford, NJ. Veranova also has UK sites in Edinburgh and Cambridge.

Related Research Articles

<span class="mw-page-title-main">Laudanum</span> Tincture of opium

Laudanum is a tincture of opium containing approximately 10% powdered opium by weight. Laudanum is prepared by dissolving extracts from the opium poppy in alcohol (ethanol).

Chloroform, or trichloromethane, is an organochloride with the formula CHCl3 and a common solvent. It is a volatile, colorless, sweet-smelling, dense liquid produced on a large scale as a precursor to refrigerants and PTFE. Chloroform was once used as an inhalational anesthetic between the 19th century and the first half of the 20th century. It is miscible with many solvents but it is only very slightly soluble in water.

<span class="mw-page-title-main">Biocon</span> Indian multinational biopharmaceutical company

Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.

<span class="mw-page-title-main">Balmoral Hotel</span> Luxury hotel in Edinburgh, Scotland

The Balmoral Hotel is a hotel and landmark in Edinburgh, Scotland. It is located in the heart of the city at the east end of Princes Street, the main shopping street beneath the Edinburgh Castle rock, and the southern edge of the New Town.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Cambrex Corporation</span> American pharmaceutical company

Cambrex Corporation is a Contract Development Manufacturing Organisation (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle, as well as active pharmaceutical ingredients (APIs). With over 2,200 employees in 7 countries across 13 locations, Cambrex operates in branded and generic markets for API and dosage form development and manufacturing.

<span class="mw-page-title-main">Healthcare in Iran</span>

For health issues in Iran see Health in Iran.

The ethics involved within pharmaceutical sales is built from the organizational ethics, which is a matter of system compliance, accountability and culture. Organizational ethics are used when developing the marketing and sales strategy to both the public and the healthcare profession of the strategy. Organizational ethics are best demonstrated through acts of fairness, compassion, integrity, honor, and responsibility.

JSC Olpha is a Latvian leading manufacturer in the chemical and pharmaceutical sector of the Baltic States.

Alfa Aesar was a supplier of reagents and materials for use in research and development, and analysis. The company had facilities in a variety of countries and manufactured many of the chemicals they sold. The company was bought by Thermo Fisher Scientific in 2015, having previously existed as part of the Johnson Matthey Fine Chemicals & Catalysts Division. In 2021, Alfa Aesar products were rebranded under the Thermo Scientific brand name.

Vectura Group Limited is a British pharmaceuticals company based in Chippenham, England which develops inhaled medicines and makes inhaler devices. The company was listed on the London Stock Exchange until it was acquired by Philip Morris International in September 2021.

<span class="mw-page-title-main">Esteve</span>

Esteve is a Spanish international pharmaceutical company headquartered in Barcelona with more than 90 years of experience. Since its founding in 1929, Esteve has extended its pharmaceutical operations to Spain, Portugal, Germany, France, and the United Kingdom, Esteve supplies medicines to more than 7 million patients worldwide.

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

<span class="mw-page-title-main">Ipca Laboratories</span> Indian multinational pharmaceutical company

Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.

<span class="mw-page-title-main">MacFarlan Smith</span> Scottish pharmaceutical research company

MacFarlan Smith is a pharmaceutical manufacturing company based in Edinburgh, Scotland, founded in 1815. After its sale from Johnson Matthey in June 2022 to Altaris Capital Partners, Macfarlan Smith rebranded as Veranova. Veranova is a CDMO specialising in the development and manufacturing of specialist and complex active pharmaceutical ingredients, or APIs. It has facilities across Europe and North America.

Ology Bioservices is a private, American biopharmaceutical company headquartered in Alachua, Florida. The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. In 2016, the company changed their strategic focus and became a biologics contract development and manufacturing company (CDMO) specializing in the manufacturing of vaccines, monoclonal antibodies, recombinant proteins, virus and nucleic acids.

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. In fiscal year 2020, it generated over $3 billion in annual revenue.

<span class="mw-page-title-main">Laurus Labs</span> Indian pharmaceutical company

Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.

<span class="mw-page-title-main">Divi's Laboratories</span> Indian pharmaceutical company

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.

<span class="mw-page-title-main">William Flockhart</span> Scottish chemist who provided Dr James Young Simpson with first chloroform for human use

William Flockhart, L.R.C.S.E. was a Scottish chemist, a pharmacist who provided chloroform to Doctor James Young Simpson for his anaesthesia experiment at 52 Queen Street, Edinburgh on 4 November 1847. This was the first use of this chemical on humans when Simpson tried it on himself and a few friends, and then used it for pain relief in obstetrics, and surgery. This changed medical practice for over a century, according to the British Medical Journal.

References

  1. 1 2 "Veranova L.P." CPHI Online. Retrieved 2024-07-02.
  2. "Veranova: Leading the Way in Synthetic Chemistry". The Medicine Maker. 2022-09-06. Retrieved 2024-07-02.
  3. 1 2 3 "Johnson Matthey Health Rebrands as Veranova". PharmTech. 2022-06-09. Retrieved 2024-07-02.
  4. "Johnson Matthey completion of Health sale – Company Announcement - FT.com". markets.ft.com. Retrieved 2024-07-02.
  5. 1 2 3 4 5 6 7 8 "A future built on the past". www.manufacturingchemist.com. Retrieved 2024-07-02.
  6. 1 2 3 4 "J. F. Macfarlan and Co - Graces Guide". www.gracesguide.co.uk. Retrieved 2024-07-02.
  7. 1 2 3 4 5 6 7 8 "Inspiring Science" (PDF). The Medicine Maker (eBook). 2015. Retrieved 2024-07-02.
  8. "Duncan Flockhart and Company Limited | Science Museum Group Collection". collection.sciencemuseumgroup.org.uk. Retrieved 2024-07-02.
  9. "Johnson Matthey Closes Sale of Health Business | CHEManager". www.chemanager-online.com. Retrieved 2024-07-02.
  10. "Johnson Matthey keeps 30% as completes sale of health arm Veranova".
  11. "JM Health Rebrands as Veranova Following Sale to Altaris Capital Partners". Yahoo Finance. 2022-06-01. Retrieved 2024-07-02.
  12. Marino, Dan (2023-05-08). "Veranova Appoints New Chief Executive Officer". Drug Development and Delivery. Retrieved 2024-07-02.
  13. "Veranova Names Mike Riley CEO". Contract Pharma. Retrieved 2024-07-02.
  14. "Veranova Completes API Expansion at Edinburgh | CHEManager". www.chemanager-online.com. Retrieved 2024-07-02.